Literature DB >> 20659105

Activation of µ-opioid receptors and block of Kir3 potassium channels and NMDA receptor conductance by L- and D-methadone in rat locus coeruleus.

Aya Matsui1, John T Williams.   

Abstract

BACKGROUND AND
PURPOSE: Methadone activates opioid receptors to increase a potassium conductance mediated by G-protein-coupled, inwardly rectifying, potassium (K(IR) 3) channels. Methadone also blocks K(IR) 3 channels and N-methyl-D-aspartic acid (NMDA) receptors. However, the concentration dependence and stereospecificity of receptor activation and channel blockade by methadone on single neurons has not been characterized. EXPERIMENTAL APPROACH: Intracellular and whole-cell recording were made from locus coeruleus neurons in brain slices and the activation of µ-opioid receptors and blockade of K(IR) 3 and NMDA channels with L- and D-methadone was examined. KEY
RESULTS: The potency of L-methadone, measured by the amplitude of hyperpolarization was 16.5-fold higher than with D-methadone. A maximum hyperpolarization was caused by both enantiomers (∼30 mV); however, the maximum outward current measured with whole-cell voltage-clamp recording was smaller than the current induced by [Met](5) enkephalin. The K(IR) 3 conductance induced by activation of α(2) -adrenoceptors was decreased with high concentrations of L- and D-methadone (10-30 µM). In addition, methadone blocked the resting inward rectifying conductance (K(IR) ). Both L- and D-methadone blocked the NMDA receptor-dependent current. The block of NMDA receptor-dependent current was voltage-dependent suggesting that methadone acted as a channel blocker. CONCLUSIONS AND IMPLICATIONS: Methadone activated µ-opioid receptors at low concentrations in a stereospecific manner. K(IR) 3 and NMDA receptor channel block was not stereospecific and required substantially higher concentrations. The separation in the concentration range suggests that the activation of µ-opioid receptors rather than the channel blocking properties mediate both the therapeutic and toxic actions of methadone.
© 2010 The Authors. British Journal of Pharmacology © 2010 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20659105      PMCID: PMC3000663          DOI: 10.1111/j.1476-5381.2010.00967.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

1.  Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801.

Authors:  K A Trujillo; H Akil
Journal:  Science       Date:  1991-01-04       Impact factor: 47.728

2.  On the potassium conductance increased by opioids in rat locus coeruleus neurones.

Authors:  R A North; J T Williams
Journal:  J Physiol       Date:  1985-07       Impact factor: 5.182

Review 3.  N-methyl-D-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug development.

Authors:  K Elliott; B Kest; A Man; B Kao; C E Inturrisi
Journal:  Neuropsychopharmacology       Date:  1995-12       Impact factor: 7.853

4.  Opioids and non-opioid enantiomers selectively attenuate N-methyl-D-aspartate neurotoxicity on cortical neurons.

Authors:  D W Choi; V Viseskul
Journal:  Eur J Pharmacol       Date:  1988-10-11       Impact factor: 4.432

5.  Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice.

Authors:  E J Bilsky; C E Inturrisi; W Sadée; V J Hruby; F Porreca
Journal:  Pain       Date:  1996-12       Impact factor: 6.961

6.  Properties of opiate-receptor binding in rat brain.

Authors:  C B Pert; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1973-08       Impact factor: 11.205

7.  Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy.

Authors:  J Mao; D D Price; R L Hayes; J Lu; D J Mayer
Journal:  Brain Res       Date:  1992-12-11       Impact factor: 3.252

8.  Human spinal fluid methadone levels.

Authors:  R B Rubenstein; M J Kreek; N Mbawa; W I Wolff; R Korn; C L Gutjahr
Journal:  Drug Alcohol Depend       Date:  1978-03       Impact factor: 4.492

9.  Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception.

Authors:  E E Codd; R P Shank; J J Schupsky; R B Raffa
Journal:  J Pharmacol Exp Ther       Date:  1995-09       Impact factor: 4.030

10.  Methadone block of K+ current in squid giant fiber lobe neurons.

Authors:  F T Horrigan; W F Gilly
Journal:  J Gen Physiol       Date:  1996-02       Impact factor: 4.086

View more
  13 in total

1.  [Analgesic therapy of calciphylaxis with levomethadone : a case study].

Authors:  M Poels; R Joppich; K Gerbershagen; F Wappler
Journal:  Schmerz       Date:  2010-12       Impact factor: 1.107

2.  Characterization of the antinociceptive effects of the individual isomers of methadone after acute and chronic administrations.

Authors:  Richard W Morgan; Katherine L Nicholson
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

3.  Buprenorphine signalling is compromised at the N40D polymorphism of the human μ opioid receptor in vitro.

Authors:  Alisa Knapman; Marina Santiago; Mark Connor
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

4.  Identification of functional circuitry between retrosplenial and postrhinal cortices during fear conditioning.

Authors:  Siobhan Robinson; Caroline E Poorman; Thomas J Marder; David J Bucci
Journal:  J Neurosci       Date:  2012-08-29       Impact factor: 6.167

Review 5.  Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance.

Authors:  John T Williams; Susan L Ingram; Graeme Henderson; Charles Chavkin; Mark von Zastrow; Stefan Schulz; Thomas Koch; Christopher J Evans; Macdonald J Christie
Journal:  Pharmacol Rev       Date:  2013-01-15       Impact factor: 25.468

6.  Effect of Sinomenine on the Morphine-Dependence and Related Neural Mechanisms in Mice.

Authors:  Miao Fang; Junkui Li; Daoqi Zhu; Chaohua Luo; Chan Li; Chen Zhu; Menglin Fan; Ken Kin-Lam Yung; Zhixian Mo
Journal:  Neurochem Res       Date:  2017-11-08       Impact factor: 3.996

7.  Does PKC activation increase the homologous desensitization of μ opioid receptors?

Authors:  Seksiri Arttamangkul; William Birdsong; John T Williams
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

8.  Methadone and Ketamine: Boosting Benefits and Still More to Learn.

Authors:  Evan D Kharasch; J David Clark
Journal:  Anesthesiology       Date:  2021-05-01       Impact factor: 7.892

Review 9.  Dendritic spine remodeling and plasticity under general anesthesia.

Authors:  Simon Granak; Cyril Hoschl; Saak V Ovsepian
Journal:  Brain Struct Funct       Date:  2021-06-01       Impact factor: 3.270

10.  Characterization of methadone as a β-arrestin-biased μ-opioid receptor agonist.

Authors:  Seira Doi; Tomohisa Mori; Naoki Uzawa; Takamichi Arima; Tomoyuki Takahashi; Masashi Uchida; Ayaka Yawata; Michiko Narita; Yasuhito Uezono; Tsutomu Suzuki; Minoru Narita
Journal:  Mol Pain       Date:  2016-06-17       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.